Artia Global Partners LP

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001937964

Type: FundHoldings: 32Value: $246.6MLatest: 2025Q1

Artia Global Partners LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 32 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "ASND",
  "CNTA",
  "INSM",
  "RVMD",
  "ARGX",
  "TGTX",
  "ALNY",
  "BSX",
  "MREO",
  "SWTX",
  "TVTX",
  "JANX",
  "AZN",
  "SRRK",
  "ISRG",
  "NBIX",
  "DGX",
  "UTHR",
  "PTGX",
  "RYTM",
  "SLNO",
  "ACLX",
  "EYPT",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "ORKA",
  null,
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 32
Total Value: 246552243
Accession Number: 0001937964-25-000004
Form Type: 13F-HR
CIK: artia-global-partners-lp
Manager Name: Artia-Global-Partners-Lp

Data Enrichment

97% identified

31 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

32 positions • $246.6M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Verona Pharma plc

VRNA|925050106

Shares:538.5K

Value:$34.2M

% of Portfolio:13.9% ($34.2M/$246.6M)

46116X101

Shares:219.7K

Value:$29.0M

% of Portfolio:11.8% ($29.0M/$246.6M)

INSMED Inc

INSM|457669307

Shares:318.2K

Value:$24.3M

% of Portfolio:9.8% ($24.3M/$246.6M)

Merus N.V.

MRUS|N5749R100

Shares:424.6K

Value:$17.9M

% of Portfolio:7.2% ($17.9M/$246.6M)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:333.9K

Value:$16.1M

% of Portfolio:6.5% ($16.1M/$246.6M)

Arcellx, Inc.

ACLX|03940C100

Shares:229.1K

Value:$15.0M

% of Portfolio:6.1% ($15.0M/$246.6M)

ASTRAZENECA PLC

AZN|046353108

Shares:190.8K

Value:$14.0M

% of Portfolio:5.7% ($14.0M/$246.6M)

BOSTON SCIENTIFIC CORP

BSX|101137107

Shares:129.7K

Value:$13.1M

% of Portfolio:5.3% ($13.1M/$246.6M)

ELI LILLY & Co

LLY|532457108

Shares:15.0K

Value:$12.4M

% of Portfolio:5.0% ($12.4M/$246.6M)

QUEST DIAGNOSTICS INC

DGX|74834L100

Shares:56.7K

Value:$9.6M

% of Portfolio:3.9% ($9.6M/$246.6M)

ALNYLAM PHARMACEUTICALS, INC.

ALNY|02043Q107

Shares:28.6K

Value:$7.7M

% of Portfolio:3.1% ($7.7M/$246.6M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:100.0K

Value:$7.1M

% of Portfolio:2.9% ($7.1M/$246.6M)

ARGENX SE

ARGX|04016X101

Shares:11.3K

Value:$6.7M

% of Portfolio:2.7% ($6.7M/$246.6M)

Nuvalent, Inc.

NUVL|670703107

Shares:90.7K

Value:$6.4M

% of Portfolio:2.6% ($6.4M/$246.6M)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:172.2K

Value:$5.5M

% of Portfolio:2.2% ($5.5M/$246.6M)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:104.2K

Value:$3.7M

% of Portfolio:1.5% ($3.7M/$246.6M)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:50.0K

Value:$2.6M

% of Portfolio:1.1% ($2.6M/$246.6M)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:53.9K

Value:$2.4M

% of Portfolio:1.0% ($2.4M/$246.6M)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:90.3K

Value:$2.2M

% of Portfolio:0.9% ($2.2M/$246.6M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:160.0K

Value:$2.2M

% of Portfolio:0.9% ($2.2M/$246.6M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Verona Pharma plc(VRNAcusip925050106)	538.5K	QoQ +110.90% (+283.2K) YoY +311.71% (+407.7K)	All Managers (Combined)	$34.2M	13.9% ($34.2M/$246.6M)	QoQ +188.34% (+$22.3M) YoY +1524.61% (+$32.1M)
(cusip46116X101)✕	219.7K	QoQ 0.00% (+0) YoY +4.58% (+9.6K)	All Managers (Combined)	$29.0M	11.8% ($29.0M/$246.6M)	QoQ +57.95% (+$10.6M) YoY +99.36% (+$14.4M)
INSMED Inc(INSMcusip457669307)	318.2K	QoQ +89.49% (+150.3K) YoY +169.15% (+200.0K)	All Managers (Combined)	$24.3M	9.8% ($24.3M/$246.6M)	QoQ +109.39% (+$12.7M) YoY +656.87% (+$21.1M)
Merus N.V.(MRUScusipN5749R100)	424.6K	QoQ -8.45% (-39.2K) YoY +746.38% (+374.5K)	All Managers (Combined)	$17.9M	7.2% ($17.9M/$246.6M)	QoQ -8.36% (-$1.6M) YoY +691.12% (+$15.6M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	333.9K	QoQ +13.61% (+40.0K) YoY +168.28% (+209.4K)	All Managers (Combined)	$16.1M	6.5% ($16.1M/$246.6M)	QoQ +42.33% (+$4.8M) YoY +348.46% (+$12.5M)
Arcellx, Inc.(ACLXcusip03940C100)	229.1K	QoQ -0.30% (-700) YoY NEW(+229.1K)	All Managers (Combined)	$15.0M	6.1% ($15.0M/$246.6M)	QoQ -14.72% (-$2.6M) YoY NEW(+$15.0M)
ASTRAZENECA PLC(AZNcusip046353108)	190.8K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$14.0M	5.7% ($14.0M/$246.6M)	QoQ +12.17% (+$1.5M) YoY +8.48% (+$1.1M)
BOSTON SCIENTIFIC CORP(BSXcusip101137107)	129.7K	QoQ NEW(+129.7K) YoY NEW(+129.7K)	All Managers (Combined)	$13.1M	5.3% ($13.1M/$246.6M)	QoQ NEW(+$13.1M) YoY NEW(+$13.1M)
ELI LILLY & Co(LLYcusip532457108)	15.0K	QoQ NEW(+15.0K) YoY -83.80% (-77.6K)	All Managers (Combined)	$12.4M	5.0% ($12.4M/$246.6M)	QoQ NEW(+$12.4M) YoY -82.80% (-$59.6M)
QUEST DIAGNOSTICS INC(DGXcusip74834L100)	56.7K	QoQ NEW(+56.7K) YoY NEW(+56.7K)	All Managers (Combined)	$9.6M	3.9% ($9.6M/$246.6M)	QoQ NEW(+$9.6M) YoY NEW(+$9.6M)
ALNYLAM PHARMACEUTICALS, INC.(ALNYcusip02043Q107)	28.6K	QoQ -49.29% (-27.8K) YoY NEW(+28.6K)	All Managers (Combined)	$7.7M	3.1% ($7.7M/$246.6M)	QoQ -41.81% (-$5.5M) YoY NEW(+$7.7M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	100.0K	QoQ -79.77% (-394.4K) YoY +144.35% (+59.1K)	All Managers (Combined)	$7.1M	2.9% ($7.1M/$246.6M)	QoQ -67.85% (-$15.1M) YoY +307.92% (+$5.4M)
ARGENX SE(ARGXcusip04016X101)	11.3K	QoQ 0.00% (-0) YoY -66.96% (-22.9K)	All Managers (Combined)	$6.7M	2.7% ($6.7M/$246.6M)	QoQ -3.76% (-$261.7K) YoY -50.33% (-$6.8M)
Nuvalent, Inc.(NUVLcusip670703107)	90.7K	QoQ -55.52% (-113.3K) YoY NEW(+90.7K)	All Managers (Combined)	$6.4M	2.6% ($6.4M/$246.6M)	QoQ -59.70% (-$9.5M) YoY NEW(+$6.4M)
Scholar Rock Holding Corp(SRRKcusip80706P103)	172.2K	QoQ NEW(+172.2K) YoY NEW(+172.2K)	All Managers (Combined)	$5.5M	2.2% ($5.5M/$246.6M)	QoQ NEW(+$5.5M) YoY NEW(+$5.5M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	104.2K	QoQ -63.33% (-180.0K) YoY NEW(+104.2K)	All Managers (Combined)	$3.7M	1.5% ($3.7M/$246.6M)	QoQ -70.36% (-$8.7M) YoY NEW(+$3.7M)
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	50.0K	QoQ 0.00% (-0) YoY NEW(+50.0K)	All Managers (Combined)	$2.6M	1.1% ($2.6M/$246.6M)	QoQ -5.37% (-$150.5K) YoY NEW(+$2.6M)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	53.9K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$2.4M	1.0% ($2.4M/$246.6M)	QoQ +22.14% (+$431.4K) YoY -10.34% (-$274.5K)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	90.3K	QoQ 0.00% (-0) YoY -79.17% (-343.3K)	All Managers (Combined)	$2.2M	0.9% ($2.2M/$246.6M)	QoQ -39.98% (-$1.5M) YoY -93.86% (-$33.4M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	160.0K	QoQ +60.00% (+60.0K) YoY NEW(+160.0K)	All Managers (Combined)	$2.2M	0.9% ($2.2M/$246.6M)	QoQ +12.50% (+$239.8K) YoY NEW(+$2.2M)